FIELD: medicine, chemical-pharmaceutical industry.
SUBSTANCE: invention relates to an agent used in treatment inflammatory and degenerative joint diseases. Agent comprising hyaluronic acid and chondroitin sulfate can comprise also dimethylsulfoxide, sodium diclofenac, chlorhexidine bigluconate, cosmetic whey, medicinal comfrey roots extract and parabena extract. Also, invention relates to a method for treatment of inflammatory or degenerative joint diseases, and a device for delivery of the claimed agent to a site damaged by the disease. The claimed agent provides reducing treatment period, to enhance effectiveness of anti-inflammatory effect and to intensify regeneration of intra-articular fluid.
EFFECT: valuable medicinal properties of agent, improved treatment method.
13 cl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING INFLAMMATORY-DEGENERATIVE ARTHROPATHIES | 2010 |
|
RU2468839C2 |
| COMBINED AGENT FOR INTRAARTICULAR ADMINISTRATION | 2017 |
|
RU2737380C2 |
| EXTERNAL PREPARATION FOR TREATING ARTHROPATHIES AND SOFT TISSUE CONDITIONS | 2007 |
|
RU2377974C2 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739747C1 |
| METHOD OF TREATING INFLAMMATORY AND DEGENERATIVE-DYSTROPHIC DISEASES OF TEMPOROMANDIBULAR JOINT | 2019 |
|
RU2715310C1 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739746C1 |
| METHOD OF TREATING DEGENERATIVE AND INFLAMMATORY-DEGENERATIVE ARTHROPATHIES | 2013 |
|
RU2519119C1 |
| METHOD OF TREATING DEGENERATIVE AND INFLAMMATORY-DEGENERATIVE ARTHROPATHIES WITH ALLOPLANT BIOMATERIAL | 2015 |
|
RU2574973C1 |
| METHOD OF TREATMENT OF DEGENERATIVE AND DYSTROPHIC DISEASES OF JOINTS | 0 |
|
SU1377110A1 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739184C1 |
